Manufactured by GlaxoSmithKline (GSK), the drug Zofran was first approved for use by the Food and Drug Administration (FDA) as ondansetron – an anti-nausea remedy in a class of medications known as a serotonin 5-HT3 receptor antagonists. The drug was first introduced to the market after FDA approval in January,... Read more »

The number of product liability complaints regarding testosterone replacement therapy continues to skyrocket, with allegations that the products caused heart attacks, stroke, and debilitating blood clot injuries. Men who took supplements such as Axiron, Testim and Androgel are seeking fair compensation and justice through the legal system, based on counts... Read more »

Actos, a type 2 diabetes medication that has been linked in some studies to an increased risk of bladder cancer, is now suspected of raising the risk of other types of cancer as well. In addition to the much publicized Actos side effects to date, emerging research has determined that the... Read more »

As the number of talcum powder cancer lawsuits against Johnson & Johnson continue to mount, plaintiffs have indicated that they support a request filed by the company to centralize the litigation. All plaintiffs cite similar allegations that use of the manufacturer’s Baby Power and Shower-to-Shower body powder products around the... Read more »

On July 15, 2015, an Ohio resident and his wife filed an Actos bladder cancer lawsuit against both Takeda Pharmaceuticals and Eli Lilly, Inc. alleging severely inadequate warnings as to the increased risks associated with the Type II diabetes drug. The lawsuit, which was filed in United States District Court... Read more »

A study recently published in the American Journal of Obstetrics & Gynecology (AJOG) found results indicating that the blood thinner Xarelto (rivaroxaban) crosses the placental barrier, raising questions about its safety for use in pregnant women. The study adds to concerns about Xarelto side effects that include serious bleeding problems... Read more »

An Alabama mother has filed a Zofran lawsuit against GlaxoSmithKline on behalf of her daughter. She claims the pharmaceutical giant engaged in false and misleading marketing of the drug, which caused her and her physician to believe it was safe for use by a pregnant woman. The mother was prescribed... Read more »

Some consumer health advocates are staunchly opposed to a new bill that was unanimously approved by the House Energy and Commerce Committee on May 21, 2015. H.R. 6 is the 21st Century Cures Act that is being touted by its proponents as being a bipartisan reform package to facilitate medical... Read more »

GlaxoSmithKline has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Zofran lawsuits for coordinated pretrial proceedings. As the number of product liability lawsuits filed on behalf of children born with heart defects, cleft palate and other congenital defects allegedly caused by exposure... Read more »

A leading professional organization devoted to the care and treatment of diabetes patients has announced a conference convened to review ketoacidosis as one of a handful of possible SGLT2 inhibitor side effects.   The American Association of Clinical Endocrinologists (AACE) announced plans for the conference on June 29 after receiving questions... Read more »